4Filed Aug 9, 8:00 PM ET
Procter & Gamble (PG) Raman Sundar Receives RSU Awards
$PG · PROCTER & GAMBLE CoResearch Summary
AI-generated summary of this SEC filing
Procter & Gamble (PG) Raman Sundar Receives RSU Awards
What Happened Raman Sundar G., CEO — Fabric, Home & Habitat Care at Procter & Gamble (PG), received a series of restricted stock unit (RSU) awards (derivative grants) during 2026. The Form 4 reports four award events: 28.709 RSUs (Feb 17), 33.577 RSUs (May 15), 0.315 RSUs (Jul 14) and 1,222 RSUs (Aug 6), totaling about 1,284.6 RSUs. Each grant is shown with an acquisition price of $0 because these are awards/derivative units (no cash purchase reported). These RSUs represent a contingent right to receive P&G common stock (or cash in certain plan situations) rather than an open‑market purchase.
Key Details
- Transaction dates and amounts: 2026-02-17 (28.709 RSUs), 2026-05-15 (33.577 RSUs), 2026-07-14 (0.315 RSUs), 2026-08-06 (1,222 RSUs). All reported as Grant/Award (code A) at $0.00.
- Total reported RSUs: ~1,284.601 units; aggregate value shown as $0 on the Form 4 (these are derivative awards, not purchases).
- Shares owned after transaction: not specified in the provided filing details.
- Footnote highlights: awards include dividend equivalents settled as RSUs (F1, F3); some units are retirement‑program awards and deliver on retirement or may be deferred (F3–F4, F7); adjustments to plan service/benefit calculations noted (F2); conversion/holding rules under retirement trustees/plan referenced (F5–F6).
- Timeliness: Form filed 2026-08-10 for a report period ending 2026-08-06. Filing flagged as late (L) relative to the typical Form 4 reporting window.
Context
- These transactions are derivative awards (RSUs). That means Sundar did not buy shares on the open market; he was granted contingent rights to receive shares in the future (vesting/retirement conditions apply).
- RSU and retirement‑plan awards are common forms of executive compensation and may reflect standard pay, dividend equivalents, or plan formulas rather than direct sentiment about the stock. They should be interpreted differently than open‑market purchases or sales.